Navigation Links
Biomerix Corporation Receives ISO 13485 Certification
Date:6/15/2009

Company with Innovative Biomaterial Technology Achieves Significant Milestone in CE Mark Approval Pathway

FREMONT, Calif., June 15 /PRNewswire/ -- Biomerix Corporation, a medical technologies company developing products using its novel Biomerix Biomaterial(TM), a three-dimensional scaffold for biointegrative tissue repair, announced today that it has received an ISO 13485 Certificate of Registration. Issued by the British Standards Institution (BSI), the certification indicates that Biomerix has successfully implemented a quality system that conforms to the exacting International Organization for Standardization (ISO) standards for medical devices. ISO is one of the key regulatory requirements for a CE Mark in the European Union as well as other international markets. The certification applies to the Fremont, CA location which designs, manufactures and distributes finished medical devices and the Somerset, NJ location which manufactures the Biomerix Biomaterial.

ISO 13485 is an internationally recognized standardization system which defines standards for the design, development, production and distribution of medical devices. It ensures conformity with specified quality controls in the development of safe and effective devices. Achievement of ISO 13485:2003 demonstrates Biomerix Corporation's dedication to continuously improve product quality by providing finished medical devices and polymer components that consistently meet customer and regulatory requirements.

"This certification represents a major milestone for Biomerix Corporation and demonstrates our unwavering commitment to producing high-quality devices for our customers. Meeting the ISO standards speaks to our belief in our quality management system and is an important step towards commercialization abroad," commented Kenneth G. Hayes, President and Chief Executive Officer of Biomerix Corporation.

About Biomerix Corporation

Biomerix Corporation develops and manufactures a broad portfolio of implantable medical devices based on its proprietary Biomerix Biomaterial(TM) platform technology. Constructed as an ideal biointegrative scaffold, the Biomerix Biomaterial supports tissue repair and regeneration, leading to better clinical outcomes. Biomerix strives to improve patient outcomes through the development of medical devices for soft tissue repair, neurovascular embolization, spine annular repair, cardiovascular repair and women's health indications, utilizing its innovative Biomaterial.

For more information call 888.308.3620 or visit www.biomerix.com


'/>"/>
SOURCE Biomerix Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Providence Service Corporation Announces Preliminary Results of Annual Meeting of Stockholders
2. Ted Karkus and Karkus Slate of Directors Prevail in Federal Court, Seated as Directors of The Quigley Corporation; Ted Karkus Elected Chairman of the Board
3. Hospital Corporation of America Named to Computerworlds Annual List of Best Places to Work in Information Technology
4. Genaera Corporation Board of Directors Dissolves Corporation and Forms Liquidating Trust
5. Zix Corporation Announces Review of Strategic Alternatives for e-Prescribing Business
6. Response Biomedical Corporation Announces Appointment of Vice President Finance & Administration and Chief Financial Officer
7. Sabinsa Corporation Validates Safety of Garcinia Cambogia Extract in Light of Hydroxycut Warning
8. RiskMetrics Recommends That Providence Service Corporation Stockholders Vote for Providences Director Nominees on the White Proxy Card
9. Somanetics Corporation to Release Second Quarter 2009 Financial Results and Host Conference Call June 17, 2009
10. Genaera Corporation Announces Results of Special Meeting of Stockholders
11. Angelica Corporation Raises Bar Again for Increased Patient Safety
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , ... June 24, 2016 , ... People across the ... Genome magazine’s Code Talker Award, an essay contest in which patients and their families ... to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & ... (TGIG), has initiated cultivation and processing operations at its production facility, and opened ... , Puradigm is the manufacturer of a complete system of proactive air and ...
(Date:6/24/2016)... ... June 24, 2016 , ... Venture Construction Group (VCG) sponsors ... on June 20th at the Woodmont Country Club at 1201 Rockville Pike, Rockville, Maryland, ... to helping service members that have been wounded in battle and their families. Venture ...
(Date:6/24/2016)... ... June 24, 2016 , ... Finally, a bruise cream that ... dermaka cream can be incorporated into the post-surgical treatment plans of a variety of ... , dermaka cream is very effective for bruising and causes a rapid resolution of ...
(Date:6/24/2016)... New York (PRWEB) , ... June 24, 2016 , ... ... marijuana patients optimize the ingestion of their medication by matching users with high quality ... users to compare pieces with no commitment. , Inhale was founded by two brothers, ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on the ... announced that patient enrollment in its ongoing randomized ... has exceeded 50% of its 24-patient target. Capricor ... the third quarter of 2016, and to report ...
(Date:6/23/2016)... BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a ... second affiliate in Latin America . ... ... ... ...
(Date:6/23/2016)... , June 23, 2016  Experian ... integrating and transforming the patient payment and ... several innovative new products and services that ... its revenue cycle offerings. These award-winning solutions ... efficient workflows, remain compliant in an ever-changing ...
Breaking Medicine Technology: